Prevention of Ventilator Associated Pneumonia (Covidien Sponsored)

Prevention of VAP

SHEA/IDSA Healthcare Associated Infections GUIDELINES App brought to you courtesy of Guideline Central. All of these titles are available for purchase on our website, GuidelineCentral.com. Enjoy!

Issue link: https://eguideline.guidelinecentral.com/i/507114

Contents of this Issue

Navigation

Page 1 of 7

Ventilator-Associated Pneumonia Table 1. Summary of Recommendations for Preventing Ventilator-Associated Pneumonia (VAP) in Adult Patients Recommendation Rationale Best practices Good evidence that the intervention decreases the average duration of mechanical ventilation, length of stay, mortality, and/or costs; benefits likely outweigh risks Special approaches Good evidence that the intervention improves outcomes but insufficient data available on possible risks May lower VAP rates but insufficient data to determine impact on duration of mechanical ventilation, length of stay, or mortality Generally NOT recommended Lowers VAP rates but ample data suggest no impact on duration of mechanical ventilation, length of stay, or mortality No impact on VAP rates, average duration of mechanical ventilation, length of stay, or mortality c No recommendation No impact on VAP rates or other patient outcomes, unclear impact on costs a ere are very few data on head-of-bed elevation, but it is classified as a basic practice because of its simplicity, ubiquity, low cost, and potential benefit. b ere are abundant data on the benefits of digestive decontamination but insufficient data on the long-term impact of this strateg y on antimicrobial resistance rates. c May be indicated for reasons other than VAP prevention. Key Points Î Although surveillance rates hover near zero, clinical surveys suggest that 5%-15% of ventilated patients develop nosocomial pneumonias. Î The attributable mortality of VAP is estimated to be approximately 10% but varies considerably for different kinds of patients.

Articles in this issue

view archives of Prevention of Ventilator Associated Pneumonia (Covidien Sponsored) - Prevention of VAP